BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burnstock G, Jacobson KA, Christofi FL. Purinergic drug targets for gastrointestinal disorders. Curr Opin Pharmacol 2017;37:131-41. [PMID: 29149731 DOI: 10.1016/j.coph.2017.10.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Shi W, Miao Y, Gan J, Guan Q, Ran J. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13. Bioengineered 2021;12:6286-304. [PMID: 34494914 DOI: 10.1080/21655979.2021.1971029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Evangelinellis MM, Souza RF, Mendes CE, Castelucci P. Effects of a P2X7 receptor antagonist on myenteric neurons in the distal colon of an experimental rat model of ulcerative colitis. Histochem Cell Biol 2021. [PMID: 34626216 DOI: 10.1007/s00418-021-02039-z] [Reference Citation Analysis]
3 Dal Ben D, Antonioli L, Lambertucci C, Fornai M, Blandizzi C, Volpini R. Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases. Front Pharmacol 2018;9:212. [PMID: 29593540 DOI: 10.3389/fphar.2018.00212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
4 Schneider R, Leven P, Glowka T, Kuzmanov I, Lysson M, Schneiker B, Miesen A, Baqi Y, Spanier C, Grants I, Mazzotta E, Villalobos-Hernandez E, Kalff JC, Müller CE, Christofi FL, Wehner S. A novel P2X2-dependent purinergic mechanism of enteric gliosis in intestinal inflammation. EMBO Mol Med 2021;13:e12724. [PMID: 33332729 DOI: 10.15252/emmm.202012724] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Inami A, Kiyono H, Kurashima Y. ATP as a Pathophysiologic Mediator of Bacteria-Host Crosstalk in the Gastrointestinal Tract. Int J Mol Sci 2018;19:E2371. [PMID: 30103545 DOI: 10.3390/ijms19082371] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 Bharucha AE, Brookes SJ. Neurophysiologic Mechanisms of Human Large Intestinal Motility ☆. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 517-64. [DOI: 10.1016/b978-0-12-809954-4.00023-2] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Seguella L, Gulbransen BD. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol 2021;18:571-87. [PMID: 33731961 DOI: 10.1038/s41575-021-00423-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Dal Ben D, Antonioli L, Lambertucci C, Spinaci A, Fornai M, D'Antongiovanni V, Pellegrini C, Blandizzi C, Volpini R. Approaches for designing and discovering purinergic drugs for gastrointestinal diseases. Expert Opin Drug Discov 2020;15:687-703. [PMID: 32228110 DOI: 10.1080/17460441.2020.1743673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Magalhães HIR, Castelucci P. Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor. World J Gastroenterol 2021; 27(46): 7909-7924 [DOI: 10.3748/wjg.v27.i46.7909] [Reference Citation Analysis]
10 Prasad H, Shenoy AR, Visweswariah SS. Cyclic nucleotides, gut physiology and inflammation. FEBS J 2020;287:1970-81. [PMID: 31889413 DOI: 10.1111/febs.15198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 DiCello JJ, Rajasekhar P, Eriksson EM, Saito A, Gondin AB, Veldhuis NA, Canals M, Carbone SE, Poole DP. Clathrin and GRK2/3 inhibitors block δ-opioid receptor internalization in myenteric neurons and inhibit neuromuscular transmission in the mouse colon. Am J Physiol Gastrointest Liver Physiol 2019;317:G79-89. [PMID: 31091149 DOI: 10.1152/ajpgi.00085.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Burnstock G. Introduction to Purinergic Signaling. Methods Mol Biol 2020;2041:1-15. [PMID: 31646477 DOI: 10.1007/978-1-4939-9717-6_1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
13 Guerra Martinez C. P2X7 receptor in cardiovascular disease: The heart side. Clin Exp Pharmacol Physiol 2019;46:513-26. [PMID: 30834550 DOI: 10.1111/1440-1681.13079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
14 Baqi Y, Müller CE. Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery. Drug Discov Today 2019;24:325-33. [PMID: 30291899 DOI: 10.1016/j.drudis.2018.09.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
15 Buccioni M, Dal Ben D, Lambertucci C, Martí Navia A, Ricciutelli M, Spinaci A, Volpini R, Marucci G. New sensible method to quantize the intestinal absorption of receptor ligands. Bioorg Med Chem 2019;27:3328-33. [PMID: 31230970 DOI: 10.1016/j.bmc.2019.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]